Incidence, recurrence, and case fatality rates for myocardial infarction in southwestern France, 1985 to 1993

Heart

Volumn 84, Issue 2, 2000, Pages 171-175

  Marques Vidal, P ^a   Ruidavets, J B ^a   Cambou, J P ^a   Ferrieres J ^a  

^a INSERM   (France)

Author keywords

Case fatality; Myocardial infarction

Indexed keywords

ADULT; ARTICLE; DATA ANALYSIS; FRANCE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

EID: 0033867559     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.84.2.171     Document Type: Article

References (37)

1. Cambou JP, Ferrières J, Ruidavets JB, et al. Epidemiologie à l'échelle européenne et française de l'infarctus du myocarde. Arch Mal Coeur Vaiss 1996;89(suppl III):13-18.
2. Ferrières J, Arveiler D, Amouyel P, et al. Epidémiologie de la mort subite coronaire en France (1985-1992). Arch Mal Coeur Vaiss 1997;90:483-7.
3. Sans S, Kesteloot H, Kromhout D, et al. The burden of cardiovascular diseases mortality in Europe. Eur Heart J 1997;18:1231-48.
4. Rosamond WD, Chambless LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998;339:861-7.
5. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-9.
6. GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
7. WHO MONICA Project (prepared by Tunstall-Pedoe H, Kuulasmaa K, et al.) Myocardial infarction and coronary deaths in the World Health Organisation MONICA Project. Registration procedures, event rates and case fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612.
8. Marques-Vidal P, Ferrières J, Metzger M-H, et al. Trends in coronary heart disease morbidity and mortality and acute coronary care and case fatality from 1985-1989 in southern Germany and south-western France. Eur Heart J 1997;18:816-21.
9. Evans AE, Ruidavets JB, McCrum EE, et al. Autres pays, autres coeurs? Dietary patterns, risk factors and ischaemic heart disease in Belfast and Toulouse. Q J Med 1995;88: 469-77.
10. Marques-Vidal P, Ferrières J, Ruidavets JB, et al. Evolution du dépistage et de la prise en charge de l'hypertension artérielle et de l'hypercholestérolémie chez les hommes en Haute-Garonne. Rev Epidémiol Santé Publ 1996;44: 193-9.
11. WHO MONICA Project Principal Investigators (prepared by Tunstall-Pedoe H). The World Health Organization MONICA Project (MONItoring trends and determinants in CArdiovascular disease): a major international collaboration. J Clin Epidemiol 1988;41:105-14.
12. WHO MONICA Project. WHO MONICA project: objectives and design. Int J Epidemiol 1989;19:529-37.
13. WHO MONICA Project Principal Investigators. The WHO MONICA project: a worldwide monitoring system for cardiovascular diseases. In: World Health statistics annual. Geneva: World Health Organisation, 1989:27-152.
14. WHO MONICA Project (prepared by Tuomilehto J, Kuulasmaa K). WHO MONICA project: assessing CHD mortality and morbidity. Int J Epidemiol 1989;18: S38-45.
15. Lang T, Ducimetière P, Arveiler D, et al. Is hospital care involved in inequalities in coronary heart disease mortality? Results from the French WHO-MONICA project in men aged 30-64. J Epidemiol Community Health 1998;52:665-71.
16. Waterhouse J, Muir CS, Correa P, et al. Cancer incidence in five continents. Lyon: International Agency for Research on Cancer, 1976.
17. Salomaa V, Arstila M, Kaarsalo E, et al. Trends in the incidence of and mortality from coronary heart disease in Finland, 1983-1988. Am J Epidemiol 1992;136:1303-15.
18. Salomaa V, Miettinen H, Kuulasmaa K, et al. Decline of coronary heart disease mortality in Finland during 1983 to 1992: roles of incidence, recurrence, and case-fatality. Circulation 1996;94:3130-7.
19. Dobson AJ, Alexander HM, Heller RF, et al. Trends in ischaemic heart disease in the Hunter region of New South Wales 1985-1989. Med J Aust 1991;155:602-4, 608.
20. The Nova Scotia-Saskatchewan Cardiovascular Disease Epidemiology Group. Trends in incidence and mortality from acute myocardial infarction in Nova Scotia and Saskatchewan 1974 to 1985. The Nova Scotia-Saskatchewan Cardiovascular Disease Epidemiology Group. Can J Cardiol 1992;8:253-8.
21. Brophy JM. The epidemiology of acute myocardial infarction and ischemic heart disease in Canada: data from 1976 to 1991. Can J Cardiol 1997;13:474-8.
22. Tunstall-Pedoe H, Kuulasmaa K, Mähönen M, et al. Contribution of trends in survival and coronary event rates to changes in coronary heart disease mortality: ten-year results from 37 WHO MONICA project populations. Lancet 1999;353:1547-57.
23. Marques-Vidal P, Cambou JP, Evans A, et al. Medical treatment of myocardial infarction in France and Northern Ireland: results from the ECTIM study. Eur Heart J 1995; 16:348-53.
24. Wilkinson P, Laji K, Ranjadayalan K, et al. Acute myocardial infarction in women: survival analysis in first six months. BMJ 1994;309:566-9.
25. Herholz H, Goff DC, Ramsey DJ, et al. Women and Mexican Americans receive fewer cardiovascular drugs following myocardial infarction than men and non-hispanic whites: the Corpus Christi Heart Project, 1988-1990. J Clin Epidemiol 1996;49:279-87.
26. Marrugat J, Antó JM, Sala J, et al. Influence of gender in acute and long-term cardiac mortality after a first myocardial infarction. J Clin Epidemiol 1994;47:111-18.
27. Malacrida R, Genoni M, Maggioni AP, et al. A comparison of the early outcome of acute myocardial infarction in women and men. N Engl J Med 1998;338:8-14.
28. Gurwitz JH, McLaughlin TJ, Willison DJ, et al. Delayed hospital presentation in patients who have had acute myocardial infarction. Ann Intern Med 1997;126:593-9.
29. Ferrières J, Cambou JP, Ruidavets JB, et al. Comparaison du pronostic et du traitement de l'infarctus du myocarde en Haute-Garonne entre 1986 et 1989. Arch Mal Coeur Vaiss 1992;85:1463-9.
30. Bellon M, Cambou JP, Ferrières J, et al. Un infarctus moins meurtrier? 5 ans de données du registre MONICA Toulouse. Rev Prat 1993;7:32-40.
31. Ferrières J, Cambou JP, Ruidavets JB, et al. Trends in acute myocardial infarction prognosis and treatment in Southwestern France between 1985 and 1990 (the MONICA Project-Toulouse). Am J Cardiol 1995;75:1202-5.
32. Sigwart U, Puel J, Mirkovitch J, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987;316:701-7.
33. Amouyel P, Arveiler D, Cambou JP, et al. Myocardial infarction lethality gradient in three French regions: the influence of acute coronary care. Int J Epidemiol 1994;23:700-9.
34. Capewell S, Morrison CE, McMurray JJ. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart 1999;81:380-6.
35. Martin CA, Hobbs M, Armstrong BK, et al. Trends in the incidence of myocardial infarction in Western Australia between 1971 and 1982. Am J Epidemiol 1989;129:655-68.
36. Sigufsson N, Sigvaldason H, Steingrimsdottir L, et al. Decline in ischaemic heart disease in Iceland and change in risk factor levels. BMJ 1991;302:1371-5.
37. McGovern PG, Pankow JS, Shahar E, et al. Recent trends in acute coronary heart disease - mortality, morbidity, medical care, and risk factors. N Engl J Med 1996;334:884-90.